These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 39329757)
1. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets. Cortes Ballen AI; Amosu M; Ravinder S; Chan J; Derin E; Slika H; Tyler B Cells; 2024 Sep; 13(18):. PubMed ID: 39329757 [TBL] [Abstract][Full Text] [Related]
5. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. Choi BD; Gerstner ER; Frigault MJ; Leick MB; Mount CW; Balaj L; Nikiforow S; Carter BS; Curry WT; Gallagher K; Maus MV N Engl J Med; 2024 Apr; 390(14):1290-1298. PubMed ID: 38477966 [TBL] [Abstract][Full Text] [Related]
6. Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion. De Fazio E; Pittarello M; Gans A; Ghosh B; Slika H; Alimonti P; Tyler B Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473812 [TBL] [Abstract][Full Text] [Related]
7. Identification of MGMT promoter methylation as a specific lipid metabolism biomarker, reveals the feasibility of atorvastatin application in glioblastoma. Hao Z; Wang J; Lv Y; Wu W; Zhang S; Hao S; Chu J; Wan H; Feng J; Ji N Metabolism; 2024 Apr; 153():155794. PubMed ID: 38301843 [TBL] [Abstract][Full Text] [Related]
8. Emerging Lipid Targets in Glioblastoma. Darwish A; Pammer M; Gallyas F; Vígh L; Balogi Z; Juhász K Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254886 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma. Li HY; Feng YH; Lin CL; Hsu TI Mitochondrion; 2024 Mar; 75():101836. PubMed ID: 38158149 [TBL] [Abstract][Full Text] [Related]
10. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma. Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462 [TBL] [Abstract][Full Text] [Related]
11. CD147: an integral and potential molecule to abrogate hallmarks of cancer. Nyalali AMK; Leonard AU; Xu Y; Li H; Zhou J; Zhang X; Rugambwa TK; Shi X; Li F Front Oncol; 2023; 13():1238051. PubMed ID: 38023152 [TBL] [Abstract][Full Text] [Related]
12. Microglia promote anti-tumour immunity and suppress breast cancer brain metastasis. Evans KT; Blake K; Longworth A; Coburn MA; Insua-Rodríguez J; McMullen TP; Nguyen QH; Ma D; Lev T; Hernandez GA; Oganyan AK; Orujyan D; Edwards RA; Pridans C; Green KN; Villalta SA; Blurton-Jones M; Lawson DA Nat Cell Biol; 2023 Dec; 25(12):1848-1859. PubMed ID: 37957324 [TBL] [Abstract][Full Text] [Related]
13. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. Ostrom QT; Price M; Neff C; Cioffi G; Waite KA; Kruchko C; Barnholtz-Sloan JS Neuro Oncol; 2023 Oct; 25(12 Suppl 2):iv1-iv99. PubMed ID: 37793125 [TBL] [Abstract][Full Text] [Related]
14. HK3 stimulates immune cell infiltration to promote glioma deterioration. Li S; Li Z; Wang X; Zhong J; Yu D; Chen H; Ma W; Liu L; Ye M; Shen R; Jiang C; Meng X; Cai J Cancer Cell Int; 2023 Oct; 23(1):227. PubMed ID: 37779195 [TBL] [Abstract][Full Text] [Related]
16. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339 [TBL] [Abstract][Full Text] [Related]